Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Mosenergo increased electricity generation by 1.5%

10/16/23 MSNG

Rosgosstrakh reported for 9 months of 2023 by RAS

10/16/23 RGSS

Moscow Exchange bought 5% of investment platform Zorko

10/16/23 MOEX

RussNeft reported for 9 months of 2023 by RAS

10/16/23 RNFT

Segezha Group sent kraft paper with a new container transportation service along the Northern Sea Route

10/16/23 SGZH

Softline is preparing to place an additional issue of 40 mln shares

10/16/23 SOFL

Krasny Oktyabr was the first in Russia to receive a halal certificate

10/16/23 KROT

NTB expands the list of assets available at commodity auctions

10/16/23 MOEX

Fix Price has been listed on AIX

10/16/23 FIXP

Samolet Group bought the developer MITs

10/16/23 SMLT